PhD or foreign academic equivalent in Pharmacy, Molecular Biology, Cellular Biology, Toxicology, Immunology or a highlyrelated field of study with an academic or industrial background in the following i medical device, drug, biologics, and cell tissuebased product regulations i.e. 21 CFR 820, 21 CFR 1271, etc.; ii planning, conducting, and managing in vitro research activities; iii conducting and managing GLP toxicity and biocompatibility studies; and iv technical report writing proficiency in support of regulatory submissions.
Categories: eb3
0 Comments